Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis
- DOI
- 10.1093/ofid/ofag279
- Published
- 2026-04-28
- Container
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ofid/ofag279,
title = {Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis},
author = {Jennifer H Ku and Lei Qian and Lina S Sy and Bradley K Ackerson and Emily Rayens and Yi Luo and Sijia Qiu and Lanfang Xu and Gina S Lee and Punam P Modha and Cheyne F Hoke and Cynthia Joe and Britta I Amundsen and Jean-Yves Pirçon and Lauriane Harrington and Nicolas Lecrenier and David Singer and Elizabeth M La and Andrew G Allmon and Dominique Luyts and Hung-Fu Tseng},
year = {2026},
journal = {Open Forum Infectious Diseases},
doi = {10.1093/ofid/ofag279},
url = {https://doi.org/10.1093/ofid/ofag279}
}RIS
TY - JOUR TI - Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis AU - Jennifer H Ku AU - Lei Qian AU - Lina S Sy AU - Bradley K Ackerson AU - Emily Rayens AU - Yi Luo AU - Sijia Qiu AU - Lanfang Xu AU - Gina S Lee AU - Punam P Modha AU - Cheyne F Hoke AU - Cynthia Joe AU - Britta I Amundsen AU - Jean-Yves Pirçon AU - Lauriane Harrington AU - Nicolas Lecrenier AU - David Singer AU - Elizabeth M La AU - Andrew G Allmon AU - Dominique Luyts AU - Hung-Fu Tseng PY - 2026 JO - Open Forum Infectious Diseases DO - 10.1093/ofid/ofag279 UR - https://doi.org/10.1093/ofid/ofag279 ER -
APA
Ku, J. H., Qian, L., Sy, L. S., Ackerson, B. K., Rayens, E., Luo, Y., Qiu, S., Xu, L., Lee, G. S., Modha, P. P., Hoke, C. F., Joe, C., Amundsen, B. I., Pirçon, J., Harrington, L., Lecrenier, N., Singer, D., La, E. M., Allmon, A. G., Luyts, D., & Tseng, H. (2026). Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofag279
Source records
- crossref · retrieved 2026-09-25T06:20:20.361Z